July 9, 2021

Given the recent and abundant evidence that the S1 subunit of the SARS-CoV-2 spike protein damages blood vessels, is it perhaps more than likely that the spike is being cleaved and the cleaved S1 unit is attacking blood vessels? 

If one notes the “side effects" of the spike protein therapies, they are PRECISELY the same as VASCULITIS:

  • Hay fever
  • Fever
  • Loss of appetite and weight loss
  • Joint and muscle pain
  • Fatigue
  • Cough Abdominal pain and gastrointestinal bleeding
  • Weakness, fatigue or a general feeling of being unwell
  • Rash or skin sores
  • Pain, numbness and tingling in your hands and feet
  • Severe abdominal pain
  • Shortness of breath

If the blood vessels in the heart are being attacked by the spike, this would cause Acute Coronary Syndrome. This chorus now sounds all too familiar:

  • Chest pain (angina) or discomfort, often described as aching, pressure, tightness or burning
  • Pain spreading from the chest to the shoulders, arms, upper abdomen, back, neck or jaw Nausea or vomiting
  • Indigestion
  • Shortness of breath (dyspnea)
  • Sudden, heavy sweating (diaphoresis)
  • Lightheadedness, dizziness or fainting
  • Unusual or unexplained fatigue
  • Feeling restless or apprehensive

Investigation into biomarkers for vasculitis in recipients of spike protein therapies must be done immediately. All spike protein therapies must be paused while this possibility is investigated.

Referenced/Related Papers


Acute coronary syndrome

Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein